<scp>C</scp> ontinuous glucose monitoring‐based <scp>time‐in‐range</scp> using insulin glargine 300 units/ <scp>ml</scp> versus insulin degludec 100 units/ <scp>ml</scp> in type 1 diabetes: The <scp>head‐to‐head</scp> randomized controlled <scp>InRange</scp> trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

C ontinuous glucose monitoring‐based time‐in‐range using insulin glargine 300 units/ ml versus insulin degludec 100 units/ ml in type 1 diabetes: The head‐to‐head randomized controlled InRange trial

Published:2022-11-14 Issue:2 Volume:25 Page:545-555
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Battelino Tadej¹^ORCID,Danne Thomas²^ORCID,Edelman Steve V.³,Choudhary Pratik⁴,Renard Eric⁵^ORCID,Westerbacka Jukka⁶,Mukherjee Bhaswati⁶^ORCID,Pilorget Valerie⁶,Coudert Mathieu⁶,Bergenstal Richard M.⁷^ORCID

Affiliation:

1. UMC‐University Children's Hospital, Faculty of Medicine University of Ljubljana Ljubljana Slovenia

2. Diabetes Centre for Children and Adolescents Children's and Youth Hospital “Auf Der Bult” Hannover Germany

3. University of California San Diego La Jolla California

4. Diabetes Research Centre University of Leicester Leicester UK

5. Department of Endocrinology, Diabetes and Nutrition, Montpellier University Hospital University of Montpellier Montpellier France

6. Sanofi Paris France

7. International Diabetes Center HealthPartners Institute Minneapolis

Funder

Sanofi

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14898

Reference33 articles.

1. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis

2. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes

3. Fear of hypoglycaemia in adults with Type 1 diabetes

4. The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

5. Differences between patients with type 1 diabetes with optimal and suboptimal glycaemic control: A real‐world study of more than 30 000 patients in a US electronic health record database

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time‐in‐range derived from self‐measured blood glucose in people with type 2 diabetes advancing to iGlarLixi: A participant‐level pooled analysis of three phase 3 LixiLan randomized controlled trials;Diabetes, Obesity and Metabolism;2024-09-08

2. The future is here: an overview of technology in diabetes;Diabetologia;2024-08-30

3. Continuous Glucose Monitoring-Derived Glucometrics in Adults with Type 1 Diabetes When Switching Basal Insulins;Diabetes Technology & Therapeutics;2024-08-01

4. Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials;Diabetologia;2024-07-22

5. A Comparison of the Rates of Clock-Based Nocturnal Hypoglycemia and Hypoglycemia While Asleep Among People Living with Diabetes: Findings from the Hypo-METRICS Study;Diabetes Technology & Therapeutics;2024-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3